460
Foghorn Therapeutics Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
351
FY23:
240
FY24:
250
FY25:
163
(positive)
Change from FY21 to FY25
millions USD
FY21:
60.2
FY22:
53.5
FY23:
45.7
FY24:
34.4
FY25:
34.9
Total assets
Change from FY21 to FY25
millions USD
FY21:
520
FY22:
405
FY23:
286
FY24:
284
FY25:
198
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
48.7
FY22:
55.2
FY23:
58.4
FY24:
67.0
FY25:
59.7
(negative)
Change from FY21 to FY25
millions USD
FY21:
374
FY22:
350
FY23:
305
FY24:
263
FY25:
247
(positive)
Change from FY21 to FY25
millions USD
FY21:
96.9
FY22:
0.11
FY23:
−77.2
FY24:
−45.5
FY25:
−109
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
520
FY22:
405
FY23:
286
FY24:
284
FY25:
198
All amounts in millions USD